2022 annual financial data
Kalaris Therapeutics 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -14,006,000 USD and net income was -15,485,000 USD.
Operating cash flow was -9,779,000 USD.
Get free Kalaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,006,000 USD
- Net income
- -15,485,000 USD
- Operating cash flow
- -9,779,000 USD